Immunovant (IMVT) Stock Price
$16.16 3.8%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
6 -
Technical
5
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Immunovant, AI stock picks, stock alerts and much more.
IMVT AI Stock Analysis
AI stock analysis for IMVT is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Immunovant (IMVT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Immunovant (IMVT) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Immunovant (IMVT), currently trading at $16.16, will... Sign up to access price prediction.
About IMVT
-
Immunovant, Inc.
-
Symbol
IMVT
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
2.8B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$19.97 1.4% |
8 |
 |
Inovio Pharmaceuticals INO |
$2.38 10.2% |
2 |
 |
Moderna MRNA |
$23.51 7.4% |
4 |
 |
Anavex Life Sciences AVXL |
$9.37 2.2% |
5 |
 |
BridgeBio Pharma BBIO |
$51.21 2.6% |
6 |
News
IMVT Alternative Data
Web Traffic
Immunovant receives an estimated 10619 monthly visitors to immunovant.com, which is up by 18.3% over the last month.
-
Web Traffic
10619
-
Change from Previous Month
18.3%
-
3 Month Change
56.1%
-
YoY Change
56.1%
Job Postings
Immunovant currenly has an estimated 3 open job postings.
-
Job Postings
3
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
200%
-
YoY Change
200%
LinkedIn Employees
According to LinkedIn, Immunovant has 356 employees, down by -1.4% over the last month.
-
LinkedIn Employees
356
-
Daily Change
0%
-
1 Month Change
1.4%
-
3 Month Change
1.9%
-
YoY Change
1.9%
Reddit Mentions
Immunovant has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Immunovant is 37 out of 100 (bearish).
-
Business Outlook
37
-
Change from Previous Month
0%
-
3 Month Change
27.5%
-
YoY Change
27.5%
LinkedIn Followers
17,498 are following Immunovant on LinkedIn.
-
LinkedIn Followers
17498
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
Immunovant was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
IMVT Financials
IMVT Key Metrics
-
Total Revenue
$0
-
Net Income
-$111.1M
-
Earnings per Share
-$0.76
-
Free cash flow
-$100.6M
-
EBITDA
-$114.2M
-
EBITDA Ratio
0
-
Total Assets
$420.9M
IMVT 2-year Revenue & Income
IMVT 2-year Free Cash Flow
IMVT Technicals
IMVT SMA
IMVT RSI
FAQ
What's the current price of Immunovant (IMVT) Stock?
The price of an Immunovant (IMVT) share is $16.16.
What's the market cap of Immunovant?
The current market cap of Immunovant is 2.8B.
What are some stocks similar to Immunovant (IMVT) that investors often compare it to?
Immunovant (IMVT) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Immunovant's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Immunovant's stock price to be around $16.29 in 2026. Starting from the current price of $16.16, this represents a 0.8% change in price, indicating a neutral outlook for the stock.
How to buy Immunovant (IMVT) Stock?
Immunovant stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Immunovant shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.